APAD2: Effects of Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics
NCT ID: NCT00234273
Last Updated: 2013-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
10 participants
INTERVENTIONAL
2004-11-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hope Theory as Ability Determinant to Permanently Change the Adapted Physical Activity (APA) in Type 2 Diabetic Patients
NCT02733302
Rehabilitation of Type 2 Diabetes Patients.
NCT00284609
A Couples-based Approach for Increasing Physical Activity Among Adults With Type 2 Diabetes
NCT02579395
A Participatory Approach to Support Glucose Tolerance Tracking in Real-Life of Patients With Type 2 Diabetes
NCT06864546
App-technology to Increase Physical Activity Among Patients With Type 2 Diabetes
NCT03053336
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The principal objective is to assess and analyze the effects of a six month programme in Adapted Physical Activity (APA) on physical activity, compliance, and insulin resistance among type 2 diabetics.
Secondary objectives are to assess and analyze the effects of a six month programme in APA of:
* arterial tension
* weight, body composition and abdominal perimeter
* quality of life
* treatment dosage
* number of hospitalisation thick a diabetes complication acute for one year and for each patient Compare two exercise's intensity: first lactate threshold (SL1) and crossover (PCGL).
Inclusion criteria:
* type 2 diabetics
* age \> 40 years
* first education in Education Diabetics Department of University Hospital Grenoble
* sedentary patients
* HbA1c \> 7%-
* BMI \> 25
* to be affiliate disease assurance
* to give consent written and inform
Judgment criteria for physical activity compliance:
* leisure time physical activity: Modifiable Activity Questionnaire
* training note-book
Judgment criteria for resistance insulin:
* Crossover (PCGL)
* HOMA and FIRI index
* HbA1c
Programme test: Rehabilitation programme in Adapted Physical Activity (APA)
Programme test period: 6 months
Study total period: 28 months
Study period for each patient: 18 months
Safety criteria: clinical compendium undesirable events
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Therapeutic education combining dietary and rehabilitation
Therapeutic education combining dietary and rehabilitation (APA)
Rehabilitation programme in Adapted Physical Activity (APA)
Therapeutic education primarily focused on dietary
Therapeutic education primarily focused on dietary
Therapeutic education primarily focused on dietary
Therapeutic education primarily focused on dietary
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rehabilitation programme in Adapted Physical Activity (APA)
Therapeutic education primarily focused on dietary
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 40
* First education in the Education Diabetics Department of the University Hospital Grenoble
* Sedentary patients
* Hemoglobin A1c (HbA1c) \> 7%
* Body mass index (BMI) \> 25
* To be affiliated with disease assurance
* To give written and informed consent
Exclusion Criteria
* Renal disease - proteinuria stage
* Contraindication for exercise
* VO2 max \> 120% Wassermann standard
* Coronary pathology non-stabilization
* Arteriopathy stage 2 non-compensation
* Osteo-articular crippling problem
* Geographically distant
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
HALIMI Serge
Role: PRINCIPAL_INVESTIGATOR
Institut National de la Santé Et de la Recherche Médicale, France
Halimi S. Therapeutic strategies for type 2 diabetes. Rev Prat HALIMI
Role: PRINCIPAL_INVESTIGATOR
Institut National de la Santé Et de la Recherche Médicale, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Endocrinology, Diabetology and Nutrition
Grenoble, Auvergne-Rhône-Alpes, France
Endocrinology, Diabetology and Nutrition - University Hospital of Grenoble
Grenoble, Auvergne-Rhône-Alpes, France
Endocrinology, Diabetology and Nutrition Department - University Hospital of Grenoble
Grenoble, , France
HALIMI Serge
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bouvard S, Faure P, Roucard C, Favier A, Halimi S. Characterization of free radical defense system in high glucose cultured HeLa-tat cells: consequences for glucose-induced cytotoxicity. Free Radic Res. 2002 Sep;36(9):1017-22. doi: 10.1080/107156021000006671.
Halimi S, Wion-Barbot N, Lambert S, Benhamou P. [Self-monitoring of blood glucose in type 2 diabetic patients. What could we propose according to their treatment?]. Diabetes Metab. 2003 Apr;29(2 Pt 2):S26-30. French.
Halimi S. [Therapeutic strategies for type 2 diabetes]. Rev Prat. 2003 May 15;53(10):1079-85. French.
Halimi S. [Is a new therapeutic class justified in the treatment of type 2 diabetes?]. Ann Endocrinol (Paris). 2002 Apr;63(2 Pt 2):1S7-11. French.
Halimi S, Charpentier G, Grimaldi A, Grenier JL, Baut F, Germain B, Magnette J. Effect on compliance, acceptability of blood glucose self-monitoring and HbA(1c) of a self-monitoring system developed according to patient's wishes. The ACCORD study. Diabetes Metab. 2001 Dec;27(6):681-7.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DCIC 03 09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.